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Reaction between the quinolone antibacterial agent ciprofloxacin
(abbreviation cfH) and CoII in aqueous medium was studied. The
ability of ciprofloxacin to form metal complexes is highly depend-
ent on the pH value of the solution. UV spectroscopy and solubility
of ciprofloxacin  HCl were used to determine the optimal conditions
for complex isolation in the pH region between 5 and 10, where the
solubility of quinolones is very low. The isolated complex Co(cf)2 
3H2O was characterized by elemental analysis, FAB-MS, TG ana-
lysis, IR spectroscopy and magnetic measurements. Cobalt K-edge
EXAFS was used for the identification of the Co site in the com-
plex.
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INTRODUCTION
Derivatives of compounds composed of 3-carboxy-4-oxo-1,4-dihydroquino-
line (i.e. 4-quinolones) are active against a wide range of gram-negative or-
ganisms and gram-positive cocci.1 The first member of the quinolone carboxylic
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acid family of antimicrobials introduced into clinical practice, nalidixic acid,
was used in the treatment of urinary tract infections.2 A major advance in
activity occurred with the introduction of fluorine atom on position 6 into
the quinoline ring to enhance the spectrum and the potency of activity, and
with addition of piperazinyl group on position 7 to enhance permeability and
potency.3 Ciprofloxacin (1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piper-
azinyl)-3-quinoline carboxylic acid) and norfloxacin (1-ethyl-6-fluoro-1,4-di-
hydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid) are currently fluoro-
quinolones with the widest clinical use. They received Food and Drug Ad-
ministration approval in 1986 and 1987, respectively. A reduced absorption
of ciprofloxacin, when given concomitantly with antacids containing magne-
sium-aluminium, was described as early as in 1985.4 Since this report, nu-
merous investigations have extended this observation to interactions of quino-
lones with other metal ions.
The synthesis and characterization of new metal complexes with quino-
lone antibacterial agents are of great importance for understanding the
drug-metal ion interaction and for their potential pharmacological use. Low
solubility of quinolones and their complexes in pH region 5 to 10 represents
a great difficulty in preparing single crystals of quinolone metal complexes.
Only a few crystal structures where quinolone is coordinated to the metal
ion are known.5–9 On the other side, numerous crystal structures of mixed
metal complexes with coordinated quinolones and N-, S- or other O-donors
have been reported.10–16 Similarly, ionic metal-quinolone compounds can be
easily prepared.17–21
Our aim was to isolate and characterize the CoII complex with ciproflo-
xacin and to determine the optimum conditions for its isolation. In a few
preliminary analytical investigations it was shown that quinolone is coordi-
nated to the metal in the pH range above 7.17, 22–23 We were carful to avoid
quinolone supersaturation in order to prevent its co-precipitation with the
complex. We determined the molar concentrations of saturated quinolone
solutions in the low solubility pH region of 5 to 10 using UV spectroscopy.
The complex Co(cf)2  3H2O was isolated in its pure form only at pH = 8. Ele-
mental analysis, FAB-MS, TG analysis, IR spectroscopy, EXAFS and mag-
netic measurements were used for its characterization.
EXPERIMENTAL
Materials
All reagents were received from commercial sources. The solutions were prepar-
ed with twice-distilled water.
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Instrumentation
Spectrometric measurements were performed on a Perkin-Elmer UV-Vis-NIR
Lambda 19 instrument, equipped with 10-mm quartz cells.
The pH’s of the solutions were determined using a pH 540 GLP WTW (Wissen-
schaftlich-technische Werkstätten) pH-meter equipped with a WTW Sen Tix pH elec-
trode.
The elemental analysis was carried out on a Perkin-Elmer 2400 CHN microanalyzer.
Infrared spectra (IR) were recorded on a Perkin-Elmer 1720 IR Fourier Trans-
form Spectrophotometer in poly-(chlorotrifluoroethylene) oil mulls between CsI win-
dows, resolution 2 cm–1, 10 scans.
Thermogravimetric (TG) data was recorded on a Mettler TA 3000 system with
platinum crucibles at a heating rate of 5 K min–1 and dry airflow rate of 20 mL
min–1. The mass of the sample was 13.40 mg. Differential thermal analysis (DTA)
data were recorded on a Perkin-Elmer DTA 7 instrument in an alumina crucible. The
empty alumina crucible was used as reference. The heating rate was 5 K min–1 and
the sample mass 2.53 mg.
Mass spectrometry was performed on a VG-Analytical AutospecEQ instrument.
Ionization was accelerated with CsI ions with energies of 20–30 keV (Fast Atom
Bombardment, FAB). m-nitrobenzylalcohol (NBA) was used as a matrix.
Powder diffraction analyses were performed on a Guinier Camera 620 with a
Guinier Monochromator 615 using Cu-K radiation. Powder Diffraction File PDF-2
was used for data matching.24
EXAFS (Extended X-ray Absorption Fine Structure) spectra of Co(cf)2  3H2O at
Co K-edge were measured in transmission mode at the HASYLAB E4 beamline of
DESY, Hamburg. The beamline provides a focused beam from an Au-coated mirror
and a Si(111) double-crystal monochromator with 1.5 eV resolution at the Co K-edge.
Harmonics were effectively eliminated by a plane Au-coated mirror and by slight de-
tuning of the monochromator crystals using the beam stabilization feedback control.
The sample in the form of fine powder was prepared on adhesive tape. The standard
stepping progression within 1000 eV region of the Co K-edge was adopted. A refer-
ence spectrum was measured on empty tapes without the sample.
Room temperature magnetic susceptibility measurements of powdered samples
were performed with a Scherwood Scientific MBS-1 balance using HgCo(NCS)4 as
calibrant. Diamagnetic corrections were applied using Pascal’s constants and the ef-
fective magnetic moments were calculated from the expression: eff = 2.828 (MT)1/2.
Spectrophotometric Measurements
Aqueous solutions of ciprofloxacin  HCl (5.0  10–5 mol L–1) were prepared for all
integer values of pH from 2 to 11. Only 0.10 mol L–1 NaOH, 0.01 mol L–1 NaOH, 0.10
mol L–1 HCl or 0.01 mol L–1 HCl were used for the pH adjustment to avoid interac-
tions with buffer solutions. The UV absorption spectra of the solutions were recorded
in the range from 220 to 400 nm.
The solubility of ciprofloxacin  HCl was studied in the pH region 5–10 at pH =
5.0, 6.0, 7.0, 8.0, 9.0 and 10.0 in triplicate measurements. Excess drug was added to
twice-distilled water. Solutions were stirred (400 turns/min) for seven days at ambi-
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ent temperature (22 °C  0.5 °C). The necessary duration was determined in a pre-
liminary experiment. A supersaturation of the ciprofloxacin  HCl solutions was ob-
served. The drug readily dissolved, but precipitation was observed after 24 h. The
precipitated compound was ciprofloxacin as proven by powder diffraction analysis.
The pH’s of the solutions were adjusted with NaOH and HCl solutions. The pH was
measured every 24 hours and adjusted if necessary to 0.05 pH. After seven days, the
samples were filtered. The concentration of the saturated solutions was determined
with UV spectroscopy. In advance, the validity of Beer's law was checked in the con-
centration range of 5.0  10–4 mol L–1 to 1.0  10–5 mol at each pH. After appropriate
dilution into the range, the UV spectrum of each sample was recorded in the wave-
length interval from 220 to 400 nm (Figure 1). The concentration of the solution was
determined by comparison with the calibration UV spectrum with the same position
of absorption maxima.
Preparation of the Compound
The ability of ciprofloxacin to form metal complexes is very sensitive to the pH of
the solution. S. C. Wallis et al. reported the specification plots of the potentiometric
titration of CuII/ciprofloxacin solution.15 The metal ciprofloxacinate species (Cu(cf)2)
represents the main species in the solution at pH > 8. The low solubility of cipro-
floxacin in pH region between 5 and 10 is the main obstacle to the synthesis of metal
complexes, leading to a very small yield. Our experiments showed that at higher
pH’s, where the solubility of ciprofloxacin is considerably higher, the co-precipitation
of the metal hydroxide baffles the synthesis of a pure metal complex. We performed the
synthesis of the complex at ciprofloxacin / metal mole ratios 1 : 1, 2 : 1 and 3 : 1. Ex-
periments showed that the complex with ciprofloxacin / metal ratio 2 : 1 precipitated
in all the three cases. The synthesis of the compound Co(cf)2  3H2O in the pure form
is possible only when it is isolated from saturated solution of ciprofloxacin at pH = 8.
The following method was used for the synthesis. The saturated solution of ci-
profloxacin  HCl at pH = 8 was prepared. The pH was adjusted with 0.10 M NaOH.
CoCl2  6H2O was added in a mole ratio cfH / CoII = 2 : 1. The solution was stirred
and a pale rose precipitate appeared after one day. The solution was filtered, washed
with ethanol and dried at 60 °C for 2 hours. The product was insoluble in water and
organic solvents. It decomposed in diluted solutions of all strong acids. All attempts
to prepare single crystals failed.
Anal. Calcd. for C34H40N6F2O9Co (Mr = 773.65): C 52.78, H 5.22, N 10.86%; found:
C 52.99, H 4.98, N 10.68%.
RESULTS AND DISCUSSION
UV Spectroscopy and Solubility Studies
Figure 1 shows the UV absorption spectra of ciprofloxacin  HCl solution
in the wavelength interval from 220 nm to 400 nm at different pH values.
Three main maxima are observed in all spectra. The position and height of
the maxima are very sensitive to the pH of the solution. At pH = 2, the first
maximum appears at 277 nm, the second at 316 nm, and the third at 328
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nm. With increasing pH, the first maximum shifts to a lower value while
the second and third maxima shift to higher values. These changes can be
attributed to the extent of ionisation of the carboxylic group as a consequen-
ce of the removal of a proton.25 At pH = 11, the three maxima appear at 272
nm, 323 nm, and 334 nm, respectively. In this way, we were able to monitor
the pH of the diluted solutions via the position of the absorption maxima.
The absorbance of the solution in the wavelength region of the first ma-
ximum at about 275 nm was used to determine the concentration of the sa-
turated solutions of quinolone. With increasing pH, the height of the first
maximum decreases, while the other two maxima increase. The molar ab-
sorptivity of the ciprofloxacin solutions at the first absorption maximum at
pH = 2 (the position of the maximum 277 nm) is 40 500 L mol–1 cm–1, while
at pH = 11 (the position of the maximum 272 nm) it is 32 880 L mol–1 cm–1.
To avoid systematic errors, the concentration of each sample was not deter-
mined spectrometrically by the standard procedure at a single wavelength,
but instead the absorbance of the solution was systematically taken at the
position of the first maximum in the spectrum.26
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Figure 1. UV spectra of ciprofloxacin  HCl solutions at different pH values.
The solubility of ciprofloxacin  HCl in the pH range between 5 and 10 is
given in Table I. The solubility has the lowest value at pH = 7. Ross and
Riley reported the solubility of ciprofloxacin  HCl at pH = 5, 7 and 9 at 25 °C
and 37 °C.27 Their values are slightly higher, but comparable with our re-
sults. The differences probably arise from the higher temperature and a
shorter preparation time (48 hours) of their saturated solutions.
Thermal Analysis
The TG and DTA curves of the complex are presented in Figure 2. The
dehydration process of the compound takes place in a single step. The DTA
curve indicates an endothermic process that ends at 135 °C. The observed
mass change (7.14%) is in good agreement with the calculated value of 6.97%,
corresponding to the loss of three water molecules per molecule of the sub-
stance. The single step of dehydration indicates that only lattice water is in-
cluded in the structure of the compound. Pyrolysis starts at 260 °C and ends
at 460 °C and forms two sharp peaks in the DTA curve, indicating an exo-
thermic process. Co3O4 is determined as a residue of the thermal decomposi-
tion.24 The 7.16% content of cobalt in the original sample is in good agree-
ment with the calculated value (7.62%).
IR Spectroscopy
Only the most informative region in the IR spectra of Co(cf)2  3H2O and
cfH  HCl  H2O (1800–1300 cm
–1) is selected and assigned in Figure 3. In con-
trast to the spectrum of cfH  HCl  H2O (curve a), the Co(cf)2  3H2O spectrum
(curve b) shows no absorption band at 1706 cm–1, characteristic of the (C=O)
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TABLE I
Solubility (s) of ciprofloxacin  HCl at different pH valuesa








aAt 22 °C. b The sample mean. c Standard deviation of the results.
vibration of the carboxylic group. This is characteristic of ionic carboxylates. In
addition, ionic carboxylates have two absorption bands in the ranges 1650–
1510 cm–1 and 1400–1280 cm–1, which could be assigned to (O–C–O) asym-
metric and symmetric stretching vibrations, respectively.28 Comparison of cfH 
HCl  H2O and Co(cf)2  3H2O spectra shows that in the case of Co(cf)2  3H2O
complex, three new absorption bands emerge at 1582, 1559 and 1534 cm–1 and
additional weak absorption bands appear in the range of 1400–1280 cm–1. In
the spectrum of cfH  HCl  H2O, the absorption bands spread around 1490
cm–1, corresponding to the stretching vibrations of C–C and C–N bonds in qui-
nolone ring; in the Co(cf)2  3H2O spectrum, they are shifted to around 1480
cm–1. A similar IR spectrum was found for Cu(cf)2Cl2  6H2O where copper ion
is coordinated by four oxygens from two quinolone molecules (one oxygen from
pyridone and one from the carboxylic group of each molecule).7
Mass Spectrometry
In the mass spectra of the compound a strong mass peak appears at m/z
720, corresponding to Co(cf)(cfH2)
+ ion, while the mass peak for molecular
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Figure 2. TG and DTA curves of Co(cf)2  3H2O.
ion is not observed. There are also two strong mass peaks at m/z 332 and
m/z 663, corresponding to cfH2
+ and (cfH)(cfH2)
+ ions. In a previous study
we showed that, in the FAB mass spectra of ionic compounds, there were no
mass peaks of M(cf)(cfH2)
+ ions, but only strong mass peaks of cfH2
+ and
(cfH)(cfH2)
+ ions.23 However, a mass peak of M(cf)(cfH2)
+ ion was observed
in the mass spectra of coordination compounds.23
EXAFS
Information on the local coordination of Co in the compound is obtained
from the Co K-edge EXAFS spectrum. EXAFS analysis is performed with
the University of Washington programs using FEFF6 code for ab initio cal-
culation of scattering paths.29–30 Contribution of three distinct shells of Co
neighbours is found in the k2 weighted Fourier transform of the EXAFS spec-
trum (Figure 4). A very good fit of the first shell in the R range of 1.4–2.0 Å
is found with 4 oxygen atoms located at a distance of 2.06 0.01) Å from Co
atom, with a Debye-Waller factor of 0.006 0.001) Å2.
Two more distant peaks in the spectrum can be ascribed to more distant
shells of Co neighbours, i.e. carbon and oxygen atoms of the two ciprofloxacin
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Figure 3. IR spectra of cfH  HCl  H2O (a) and Co(cf)2  3H2O (b).
molecules surrounding the Co ion. However, due to a high correlation of the
fit parameters, a precise distribution of Co neighbours in the R range beyond
3.0 Å cannot be determined.
Magnetic Measurements
From the measurement of the magnetic susceptibility of Co in the com-
pound, additional information about the local coordination of Co is obtained.
Magnetic moment of 5.19 mB indicates three unpaired electrons per Co atom.
In case of a fourfold coordination of cobalt, this result indicates the tetrahe-
dral symmetry of the ligands.
CONCLUSION
The synthesis of the compound Co(cf)2  3H2O in the pure form is possi-
ble only when it is isolated from saturated solution of ciprofloxacin at pH =
8. Mass spectrometry of the compound indicates bonding of CoII ion to quino-
lone, forming Co(cf)2 molecules. Co K-edge EXAFS and magnetic suscepti-
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Figure 4. The k2 weighted Fourier transform of the Co K-edge EXAFS spectrum of
the Co(cf)2  3H2O compound calculated in the k range of 4–11 Å
–1; solid line – ex-
periment, dotted line – fit.
bility measurements show that the cobalt ion in the compound is tetrahedraly
coordinated by four oxygens. IR spectrum of the compound is similar to the
spectrum of Cu(cfH)2Cl2  6H2O, where the copper ion is coordinated to the
two pyridone and two carboxylic oxygen atoms of two quinolone molecules.7
Therefore we propose the same bonding of quinolone molecules to cobalt ion
in our compound. The proposed structure of the Co(cf)2 molecule is illus-
trated in Figure 5. Thermal analysis indicates that water molecules are in-
cluded as lattice water in the crystal structure of Co(cf)2  3H2O.
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Figure 5. The proposed structure of the Co(cf)2 molecule.
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SA@ETAK
Fizikalno-kemijsko prou~avanje interakcije iona kobalta(II)
s ciprofloksacinom
Marija Zupan~i~, Iztok Ar~on, Peter Bukovec i Alojz Kodre
Prou~avana je reakcija kinolonskog antibakterijskog agensa ciprofloksacina i iona
CoII u vodenom mediju. Sposobnost ciprofloksacina za tvorbu metalnih kompleksa,
vrlo je ovisna o pH-vrijednosti otopine. Primjenjena je UV spektroskopija i podatci o
topljivosti ciprofloksacin  HCl da bi se odredili optimalni uvjeti za izolaciju kompleksa
u podru~ju 5 < pH < 10, gdje je topljivost kinolona vrlo malena. Izolirani kompleks
Co(cf)2  3H2O okarakteriziran je elementnom analizom, FAB-MS, TG analizom, IR
spektroskopijom i magnetskim mjerenjima. Da bi se odredio polo`aj Co u kompleksu
primijenjena je tehnika »K-edge EXAFS« s kobaltom.
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